The nTRACK consortium is proud to present a 3D animation video to explain the principle of the project. It is developing a safe, scalable and highly sensitive multi-modal cell nano-imaging agent ready for testing in humans.
Stem cells will be labelled with nTRACK gold nano-particles and fully characterised for uptake, functionality, and safety. The labelled stem cells will be injected into an injured muscle and tracked using imaging systems. Functionality, activity and nonclinical safety will be evaluated. Regulatory and commercialization aspects will be addressed to foster a prompt clinical translation and exploitation.